Desitin sells global rights of Sulthiame in sleep apnea to Apnimed, Inc.06.05.2025: “Desitin is proud to have contributed to the ongoing clinical development of sulthiame, an investigational compound with compelling Phase 2 efficacy data and a favourable […]
Positive study results in 298 patients with obstructive sleep apnea (OSA)11.03.2024: Positive study results in 298 patients with obstructive sleep apnea (OSA): Significant reduction of nocturnal breathing pauses with an oral investigational medicinal product after 15 […]